Suicide study: Vira
Official title A Digitally Assisted Risk Reduction Platform for Youth at High Risk for Suicide
ClinicalTrials.gov ID: NCT05920252
What this study is testing
- What it's testing
- The study will see whether a digital tool that collects phone data and lets clinicians communicate securely can improve monitoring of suicide risk factors in young people.
- Who it's for
- Young people who are considered high risk for suicide because of mental health problems.
- What's involved
- Participants will use a smartphone app that records certain activity and sleep patterns and allows secure messaging with their care team.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 13 to 18
You may be able to join if
- Written informed assent from adolescents ages 13-17 years old and permission from legal guardians, or consent from adolescents age 18 years old.
- Receiving treatment at the Intensive Adolescent and Family DBT Pgogram
- 13-18 years old
- Owns a personal smartphone (Android or iPhone 7+)
- Fluent in English
You likely can't join if
- Adolescents who require a higher level of care (i.e., are not admitted to the Intensive Outpatient DBT program)
- Adolescents who are receiving treatment at the Intensive Adolescent and Family DBT program and have already been assigned a clinician
The study team makes the final eligibility decision.
Where it is enrolling
- New York, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 13 years to 18 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at New York, New York, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.